TipRanks
Go Ultimate55% OFF

LB Pharmaceuticals, Inc. (LBRX) Drug Pipeline

Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
Lb-102SchizophreniaPhase IIINot Yet RecruitingStudy to Evaluate LB-102 for the Treatment of Adult Patients With Acute SchizophreniaDec 26, 2025
Lb-102SchizophreniaPhase IIINot Yet Recruiting52-week Open Label Safety-Tolerability StudyDec 26, 2025
Lb-102Bipolar I DisorderPhase IIRecruitingMulticenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE.Dec 26, 2025―
Lb-102SchizophreniaPhase IICompletedRandomized, Double-blinded, Placebo-controlled, Evaluating the Treatment With LB-102 in Patients With Acute SchizophreniaDec 12, 2023―

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does LB Pharmaceuticals, Inc. (LBRX) have in its pipeline
LB Pharmaceuticals, Inc. LBRX is currently developing the following drugs: Lb-102. These drug candidates are in various stages of clinical development as the company works toward FDA approval.